From October 1, 2023 to December 30, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 997,406 shares, representing 1.95% for $75 million under the buyback announced on August 10, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
83.18 USD | +0.25% | -2.71% | -2.72% |
18/06 | Haemonetics Corporation Launches Limited Market Release of its New VASCADE MVP XL Mid-Bore Venous Closure Device | CI |
12/06 | Haemonetics Shares Rise After Upgrade From Needham | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.72% | 4.24B | |
-4.92% | 182B | |
-3.70% | 102B | |
-5.29% | 66.74B | |
+10.99% | 44.89B | |
-7.70% | 45.55B | |
+6.13% | 40.62B | |
+15.96% | 30.04B | |
+14.80% | 24.34B | |
-6.63% | 23.95B |
- Stock Market
- Equities
- HAE Stock
- News Haemonetics Corporation
- Tranche Update on Haemonetics Corporation's Equity Buyback Plan announced on August 10, 2022.